Healthcare provider profile · identity verified

Nima Patel Florio, M.D.

Internal Medicine · MADISON, WI · NPI 1437538337

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1027	312
Omeprazole	Omeprazole	521	167
Levothyroxine Sodium	Levothyroxine Sodium	474	129
Amlodipine Besylate	Amlodipine Besylate	459	140
Losartan Potassium	Losartan Potassium	445	135
Lisinopril	Lisinopril	325	99
Furosemide	Furosemide	307	81
Simvastatin	Simvastatin	266	81
Rosuvastatin Calcium	Rosuvastatin Calcium	243	79
Metoprolol Tartrate	Metoprolol Tartrate	241	59
Sertraline Hcl	Sertraline Hcl	218	62
Pantoprazole Sodium	Pantoprazole Sodium	216	62
Gabapentin	Gabapentin	214	51
Hydrochlorothiazide	Hydrochlorothiazide	201	59
Metoprolol Succinate	Metoprolol Succinate	201	67
Warfarin Sodium	Warfarin Sodium	198	52
Metformin Hcl Er	Metformin Hcl	197	57
Potassium Chloride	Potassium Chloride	185	54
Fluticasone Propionate	Fluticasone Propionate	179	78
Trazodone Hcl	Trazodone Hcl	168	55
Citalopram Hbr	Citalopram Hydrobromide	154	44
Atenolol	Atenolol	152	41
Famotidine	Famotidine	150	48
Metformin Hcl	Metformin Hcl	148	44
Duloxetine Hcl	Duloxetine Hcl	144	28
Fluoxetine Hcl	Fluoxetine Hcl	128	45
Eliquis	Apixaban	121	39
Alendronate Sodium	Alendronate Sodium	119	41
Donepezil Hcl	Donepezil Hcl	93	17
Carvedilol	Carvedilol	92	29
Albuterol Sulfate Hfa	Albuterol Sulfate	90	44
Allopurinol	Allopurinol	79	23
Spironolactone	Spironolactone	77	31
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	76	22
Pravastatin Sodium	Pravastatin Sodium	73	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	72	24
Glipizide Er	Glipizide	70	22
Escitalopram Oxalate	Escitalopram Oxalate	69	17
Oxybutynin Chloride	Oxybutynin Chloride	65	15
Tamsulosin Hcl	Tamsulosin Hcl	58	17
Nystatin	Nystatin	57	34
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	55	15
Bupropion Xl	Bupropion Hcl	54	18
Mirtazapine	Mirtazapine	54	18
Clopidogrel	Clopidogrel Bisulfate	51	16
Enalapril Maleate	Enalapril Maleate	51	15
Lovastatin	Lovastatin	48	15
Benazepril Hcl	Benazepril Hcl	46	16
Propranolol Hcl	Propranolol Hcl	46	14
Ozempic	Semaglutide	45	14
Meloxicam	Meloxicam	43	16
Synthroid	Levothyroxine Sodium	43	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	12
Alprazolam	Alprazolam	41	11
Glipizide	Glipizide	41	14
Montelukast Sodium	Montelukast Sodium	41	11
Paroxetine Hcl	Paroxetine Hcl	41	12
Ventolin Hfa	Albuterol Sulfate	41	14
Buspirone Hcl	Buspirone Hcl	39	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Farxiga	Dapagliflozin Propanediol	36	suppressed
Ondansetron Odt	Ondansetron	36	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	13
Nifedipine Er	Nifedipine	34	11
Trulicity	Dulaglutide	34	suppressed
Valacyclovir	Valacyclovir Hcl	33	17
Venlafaxine Hcl Er	Venlafaxine Hcl	33	11
Xarelto	Rivaroxaban	33	suppressed
Oxycodone Hcl	Oxycodone Hcl	32	12
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Jardiance	Empagliflozin	31	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Primidone	Primidone	28	suppressed
Tresiba Flextouch U-200	Insulin Degludec	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	18
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Lorazepam	Lorazepam	25	13
Cephalexin	Cephalexin	24	18
Digoxin	Digoxin	24	suppressed
Ketoconazole	Ketoconazole	24	15
Lidocaine	Lidocaine	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	12
Fluticasone Propionate Hfa	Fluticasone Propionate	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Arnuity Ellipta	Fluticasone Furoate	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Finasteride	Finasteride	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Nystop	Nystatin	17	suppressed
Prednisone	Prednisone	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	14	suppressed
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	13	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Nyamyc	Nystatin	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Naproxen	Naproxen	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error